The SAGE Oncotest™ Approach

Machine learning-enabled live 3D cancer profiling

1

We create live 3D microtumors of the patient’s sample in a day...

2

that retain the microenvironment and heterogeneity of the sample...

3

testing multiple drugs using our proprietary technologies...

4

to identify the most effective therapy in just one week.

By using the patient’s primary live cancer tissue rather than formalin-fixed tissue of dead cancer cells, the SAGE Oncotest™ empowers oncologists and patients to identify the most effective therapy, overcoming inherent limitations of genomic testing.

Furthermore, the SAGE Oncotest™ is faster and more reproducible than legacy live-cell assays and it overcomes the limitations of organoid models.

Frequently Asked Questions

Scroll to Top

Learn how we helped 100 top brands gain success

Loading...